
Reata Pharma Tops Q3 EPS by 74c
Reata Pharma (RETA) reported Q3 EPS of ($1.47), $0.74 better than the analyst estimate of ($2.21). Revenue for the quarter came in at $540 thousand versus the consensus estimate of $1.03...
Reata Pharma (RETA) reported Q3 EPS of ($1.47), $0.74 better than the analyst estimate of ($2.21). Revenue for the quarter came in at $540 thousand versus the consensus estimate of $1.03...
Investing.com - Reata Pharma reported on Tuesday third quarter {{erl-977732||earnings that beat analysts' forecasts and revenue that fell short of expectations. Reata Pharma announced...
After-Hours Stock Movers: Imara Inc. (Nasdaq: IMRA) 19% HIGHER; Enliven Therapeutics, Inc., a clinical-stage precision oncology company focused on the discovery and development of...
Reata Pharma (RETA) reported Q2 EPS of ($1.36), $0.75 better than the analyst estimate of ($2.11). Revenue for the quarter came in at $762 thousand versus the consensus estimate of $1.55...
Reata Pharma (RETA) reported Q1 EPS of ($1.33), $0.82 better than the analyst estimate of ($2.15). Revenue for the quarter came in at $910 thousand versus the consensus estimate of $1.55...
Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Consumer Goods, Technology and Oil & Gas sectors propelled shares lower. At the close in NYSE, the Dow...
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Consumer Services, Utilities and Basic Materials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Oil & Gas, Industrials and Basic Materials sectors propelled shares higher while losses in the Healthcare,...
Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Financials, Technology and Healthcare sectors propelled shares higher while losses in the Utilities, Consumer...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.